Abstract
In humans, IL-8 (CXCL8) is a key chemokine for chemotaxis of polymorphonuclear leukocytes and monocytes/macrophages when acting on CXCR1 and CXCR2. CXCL8 activity on neutrophils includes chemotaxis and eliciting the extrusion of neutrophil extracellular traps (NETs). In this study, we show that concentrations of IL-8 that induce NETosis surpass in at least one order of magnitude those required to elicit chemoattraction in human neutrophils. IL-8-induced NETosis was less dependent on G-proteins than migration, while extracellular Ca+2 chelation similarly inhibited both processes. Reactive oxygen species (ROS) were more important for NETosis than for chemotaxis as evidenced by neutralization with N-acetyl -cysteine. Interestingly, selective blockade with anti-CXCR1 mAb inhibited NETosis much more readily than chemotaxis, while pharmacological inhibition of both CXCR1 and CXCR2, or selective inhibition for CXCR2 alone, similarly inhibited both functions. Together, these results propose a model according to which low concentrations of IL-8 in a gradient attract neutrophils to the inflammatory foci, while high receptor-saturating concentrations of IL-8 give rise to NETosis once leukocytes reach the core of the inflammatory insult.
References
Apr 1, 1988·The Journal of Experimental Medicine·J Van DammeA Billiau
Dec 16, 1987·Biochemical and Biophysical Research Communications·A WalzM Baggiolini
Mar 6, 2004·Science·Volker BrinkmannArturo Zychlinsky
Mar 10, 2007·International Journal of Immunopathology and Pharmacology·J M LeitnerB Jilma
Nov 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Laura Martínez MuñozMario Mellado
Aug 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Tobias A FuchsDenisa D Wagner
May 3, 2014·Nature Medicine·Christine SchauerMartin Herrmann
Mar 5, 2015·The Journal of Pharmacology and Experimental Therapeutics·David J NichollsCarina Kärrman Mårdh
Jul 29, 2016·Oncoimmunology·Mélanie DemersDenisa D Wagner
Nov 1, 2016·Science Translational Medicine·Juwon ParkMikala Egeblad
May 23, 2017·Theranostics·Helen HaNouri Neamati
Sep 14, 2017·Autoimmunity Reviews·Keum Hwa LeeJae Il Shin
Oct 11, 2017·Nature Reviews. Immunology·Venizelos Papayannopoulos
Sep 29, 2018·Science·Jean AlbrenguesMikala Egeblad
Nov 18, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Man NieWenqi Jiang
Aug 20, 2019·Immunity·Luis E MuñozMartin Herrmann
Apr 15, 2020·Immunity·Álvaro TeijeiraIgnacio Melero
May 7, 2020·Molecular Cancer Therapeutics·Marina LiYulia Nefedova
Jun 13, 2020·Nature·Linbin YangErwei Song
Aug 30, 2020·The Journal of Experimental Medicine·Yu ZhangFlorencia McAllister